Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-06-24 @ 9:58 AM
Study NCT ID:
NCT05214794
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis
Sponsor:
Maruho Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Systemic Sclerosis | View |
Keywords: